super-enhancers often drive the high-level expression of oncogenes, and super-enhancer inhibition by CDK7 and BET inhibitors can effectively block tumor cell proliferation and enhance survival in mouse models of disease (43, –, 45). The gene discussed is DNER; the disease is neoplasm.